• 1
    Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumor immunity. Nat Rev Immunol 2003; 3:21122.
  • 2
    Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21:57383.
  • 3
    Chen H, Paul WE. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997; 159:22409.
  • 4
    Porcelli SA, Modlin RL. The CD1 system. antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17:297329.
  • 5
    Bendelac A, Rivera MN, Park HS, Roark JH. Mouse CD1-specific NK1 T cells: development, specifity and function. Annu Rev Immunol 1997; 15:53562.
  • 6
    Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278:16269.
  • 7
    Brigl M, Brenner MB. CD1. antigen presentation and T cell function. Annu Rev Immunol 2004; 22:81790.
  • 8
    Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114:137988.
  • 9
    Kawano T, Nakayama T, Kamada N et al. Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res 1999; 59:51025.
  • 10
    Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002; 110:793800.
  • 11
    Lucas M, Gadola S, Meier U et al. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol 2003; 77:22517.
  • 12
    Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L. Cutting edge. activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999; 163:23737.
  • 13
    Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d recognition by human invariant Valpha24+ CD4 CD8 T cells. J Exp Med 1997; 186:10920.
  • 14
    Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by tetramer staining. J Exp Med 2002; 195:62536.
  • 15
    Metelitsa LS. Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells. Clin Immunol 2004; 110:26776.
  • 16
    Dellabona P, Casorati G, Friedli B, Angman L, Sallusto F, Tunnacliffe A, Roosneek E, Lanzavecchia A. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4 8 subset. J Exp Med 1993; 177:176371.
  • 17
    Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4 8 alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 1993; 178:116.
  • 18
    Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4 8 T cells. J Exp Med 1994; 180:11716.
  • 19
    Thomas SY, Hou R, Boyson JE et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 2003; 171:257180.
  • 20
    Eberl G, Lees RK, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol 1999; 162:64109.
  • 21
    Stenstrom M, Skold M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Lehuen A, Cardell S. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type. Eur J Immunol 2004; 34:5665.
  • 22
    Sandberg JK, Bhardwaj N, Nixon DF. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur J Immunol 2003; 33:58896.
  • 23
    Exley M, Porcelli S, Furman M, Garcia J, Balk S. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 1998; 188:86776.
  • 24
    Lanier LL, Chang C, Phillips JH. Human NKR-P1A. A disulfide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994; 153:241722.
  • 25
    Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000; 192:74154.
  • 26
    Sidobre S, Kronenberg M. CD1 tetramers. a powerful tool for the analysis of glycolipid-reactive T cells. J Immunol Meth 2002; 268:10721.
  • 27
    Exley MA, Tahir SM, Cheng O, Shaulov A, Joyce R, Avigan D, Sackstein R, Balk SP. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol 2001; 167:55314.
  • 28
    Gadola SD, Dulphy N, Salio M, Cerundolo V. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4 (+) and CD8alphabeta (+) T lymphocytes. J Immunol 2002; 168:551420.
  • 29
    Brigl M, Van Den Elzen P, Chen X et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 2006; 176:362534.
  • 30
    Boyson JE, Rybalov B, Koopman LA et al. CD1d and invariant NKT cells at the human maternal–fetal interface. Proc Natl Acad Sci USA 2002; 99:137416.
  • 31
    Schatz D, Cuthbertson D, Atkinson M et al. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus – a new surrogate measure of non-progression? Pediatr Diabetes 2004; 5:729.
  • 32
    Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 2004; 4:2317.
  • 33
    Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2:55768.
  • 34
    Bollyky PL, Wilson SB. CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity. Immunol Cell Biol 2004; 82:30714.
    Direct Link:
  • 35
    Workman CJ, Vignali DA. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 2003; 33:9709.
  • 36
    Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity 2004; 21:50313.
  • 37
    Wilson SB, Kent SC, Horton HF, Hill AA, Bollyky PL, Hafler DA, Strominger JL, Byrne MC. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 2000; 97:74116.
  • 38
    Wilson SB, Byrne MC. Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T cell subset. Curr Opin Immunol 2001; 13:55561.
  • 39
    Strominger JL, Byrne MC, Wilson SB. Regulation of dendritic cell subsets by NKT cells. C R Biol 2003; 326:10458.
  • 40
    Kent SC, Hafler DA, Strominger JL, Wilson SB. Noncanonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d. Hum Immunol 1999; 60:10809.
  • 41
    Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human Valpha24 natural killer T cells. J Exp Med 2002; 195:63741.
  • 42
    Wilson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391:17781.
  • 43
    Hou R, Goloubeva O, Neuberg DS, Strominger JL, Wilson SB. Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perforin expression independent of T-cell receptor activation. Immunology 2003; 110:307.
  • 44
    Deignan T, Curry MP, Doherty DG et al. Decrease in hepatic CD56 (+) T cells and V alpha 24 (+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol 2002; 37:1018.
  • 45
    Norris S, Doherty DG, Collins C, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. Natural T cells in the human liver. cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Valpha24-JalphaQ and gamma-delta T cell receptor bearing cells. Hum Immunol 1999; 60:2031.
  • 46
    Ishihara S, Nieda M, Kitayama J et al. CD8+NKR-P1A+ T cells preferentially accumulate in human liver. Eur J Immunol 1999; 29:240613.
  • 47
    Van Der Vliet HJ, Von Blomberg BM, Nishi N et al. Circulating V (alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001; 100:1448.
  • 48
    Sumida T, Sakamoto A, Murata H et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med 1995; 182:11638.
  • 49
    Tahir SMA, Cheng O, Shaulov A, Koezuka Y, Bubley GB, Wilson SB, Balk SP, Exley MA. Loss of IFN gamma production by invariant NKT cells in advanced cancer. J Immunol 2001; 167:404650.
  • 50
    Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000; 164:437581.
  • 51
    Kim CH, Butcher EC, Johnston B. Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 2002; 23:5169.
  • 52
    Lin H, Nieda M, Rozenkov V, Nicol AJ. Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells. Exp Hematol 2006; 34:28995.
  • 53
    Van Der Vliet HJ, Molling JW, Nishi N et al. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells. Cancer Res 2003; 63:41016.
  • 54
    Van Der Vliet HJ, Von Blomberg BM, Hazenberg MD et al. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J Immunol 2002; 168:14905.
  • 55
    Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109:13140.
  • 56
    Baev DV, Peng XH, Song L, Barnhart JR, Crooks GM, Weinberg KI, Metelitsa LS. Distinct homeostatic requirements of CD4+ and CD4 subsets of Valpha24-invariant natural killer T cells in humans. Blood 2004; 104:41506.
  • 57
    Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur J Immunol 2005; 35:1399407.
  • 58
    Montoya CJ, Jie HB, Al-Harthi L et al. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J Immunol 2006; 177:102839.
  • 59
    Crowe NY, Coquet JM, Berzins SP et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 2005; 202:127988.
  • 60
    Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, Balk SP, Koziel MJ. Cutting edge. Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J Immunol 2002; 168:151923.
  • 61
    Levy O, Orange JS, Hibberd P et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis 2003; 88:4853.
  • 62
    Hammond KJ, Pelikan SB, Crowe NY et al. NKT cells are phenotypically and functionally diverse. Eur J Immunol 1999; 29:76881.
  • 63
    Scotto L, Naiyer AJ, Galluzzo S et al. Overlap between molecular markers expressed by naturally occurring CD4+ CD25+ regulatory T cells and antigen specific CD4+ CD25+ and CD8+ CD28 T suppressor cells. Hum Immunol 2004; 65:297306.
  • 64
    Exley M, Garcia J, Wilson SB et al. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000; 100:747.
  • 65
    Sandberg JK, Fast NM, Palacios EH et al. Selective loss of innate CD4+ Vα24 natural killer T cells in human immunodeficiency virus infection. J Virol 2002; 76:752834.
  • 66
    Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998; 88:152934.
  • 67
    Araki M, Kondo T, Gumperz JE, Brenner MB, Miyake S, Yamamura T. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol 2003; 15:27988.
  • 68
    Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006; 354:111729.
  • 69
    Chen YG, Chen J, Osborne MA, Chapman HD, Besra GS, Porcelli SA, Leiter EH, Wilson SB, Serreze DV. cd38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T Cells in nonobese diabetic mice. J Immunol 2006; 177:293947.